|
ZNF701 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.593800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.868200E-01 |
| Normal-vs-Stage2 |
3.529400E-01 |
| Normal-vs-Stage3 |
9.823000E-01 |
| Normal-vs-Stage4 |
8.395000E-01 |
| Stage1-vs-Stage2 |
2.519600E-01 |
| Stage1-vs-Stage3 |
9.699600E-01 |
| Stage1-vs-Stage4 |
8.492800E-01 |
| Stage2-vs-Stage3 |
3.810800E-01 |
| Stage2-vs-Stage4 |
4.339200E-01 |
| Stage3-vs-Stage4 |
8.881000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.280400E-01 |
| Normal-vs-AfricanAmerican |
9.447200E-01 |
| Normal-vs-Asian |
1.927360E-01 |
| Caucasian-vs-AfricanAmerican |
3.083200E-01 |
| Caucasian-vs-Asian |
1.392380E-02 |
| AfricanAmerican-vs-Asian |
2.131600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.860200E-01 |
| Normal-vs-Female |
1.183040E-01 |
| Male-vs-Female |
7.265900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.875400E-01 |
| Normal-vs-Extreme_Weight |
4.814400E-01 |
| Normal-vs-Obese |
1.056430E-01 |
| Normal-vs-Extreme_Obese |
3.740200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.612200E-01 |
| Normal_Weight-vs-Obese |
7.780000E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.568200E-01 |
| Extreme_Weight-vs-Obese |
9.621100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.038200E-01 |
| Obese-vs-Extreme_Obese |
1.307410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.203600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.225200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.534000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.591400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.353000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.398200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.555400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.552500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.227800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.302200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.708400E-01 |
| Normal-VS-Type2 PRCC |
6.042800E-01 |
| Normal-VS-KIRP CIMP |
5.416400E-01 |
| Normal-VS-Unclassified PRCC |
1.393040E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.641980E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.612600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.255600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.918600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.044300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.901000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.787620E-01 |
| Normal-vs-N1 |
1.317200E-01 |
| Normal-vs-N2 |
2.380300E-02 |
| N0-vs-N1 |
2.077800E-02 |
| N0-vs-N2 |
8.594300E-02 |
| N1-vs-N2 |
4.454500E-02 |
|
|
